Skip to main content
SpringerLink
Log in
Book cover

Ovulation Stimulation with Gonadotropins pp 55–68Cite as

Triggering Ovulation

  • Chapter

  • 715 Accesses

Abstract

Ovulation is simply the focal destruction of the follicular wall that enables extrusion of the oocyte and follicular contents through the breach. A space of some 36–40 h passes from the initial gonadotropin surge to the follicular rupture itself, during which irreversible actions reprogram the entire structure and function of the follicle, reawaken oocyte meiosis, alter the follicular wall, and commence the process of luteinization.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Franchimont F, Hazee-Hagelstein MT, Charlet-Renard B et al (1994) Some basic mechanisms of ovulation. In: Emperaire JC (ed) The triggering of ovulation in stimulated cycles: HCG or LH? The Parthenon Publishing Group, London, pp 13–20

    Google Scholar 

  2. Hoff JD, Quidgley ME, Yen SSC (1983) Hormonal dynamics at mid-cycle: a reevaluation. J Clin Endocrinol Metab 57:792–796

    Article  CAS  PubMed  Google Scholar 

  3. Testard J, Frydman R, Feinstein MC et al (1998) Interpretation of plasma luteinizing hormone assay for the collection of mature oocytes from women: definition of a luteinizing hormone surge initiating rise. Fertil Steril 36:50–54

    Google Scholar 

  4. Cohlen BJ, TeVelde ER, Scheffer G et al (1993) The pattern of the luteinizing hormone surge in spontaneous cycles is correlated to the probability of conception. Fertil Steril 60:413–417

    CAS  PubMed  Google Scholar 

  5. Bianchi V, Dal Prato L, Maccolini A et al (2009) Inadvertent recombinant follicle stimulating hormone bolus instead of human chorionic gonadotropin leads to the retrieval of competent oocytes in IVF program. Fertil Steril 92:1747.e1–1747.e3

    Article  Google Scholar 

  6. Lamb JD, Shen S, McCulloch C et al (2011) Follicle stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial. Fertil Steril 95:1655–1660

    Article  CAS  PubMed  Google Scholar 

  7. Shalom-Paz E, Marzal A, Wiser A et al (2014) Does optimal follicular size vary between clomiphene citrate and gonadotropin treatments? Gynecol Endocrinol 30:107–110

    Article  CAS  PubMed  Google Scholar 

  8. Da Silva A, Arbo E, Franchin R (2012) Early versus late HMG administration in mild-stimulated IUI cycles: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 164:156–160

    Article  PubMed  Google Scholar 

  9. Loumaye E, Engrand P, Howles CM, O’Dean L (1997) An assessment of the role of serum luteinizing hormone and estradiol response to follicle stimulating hormone on the in vitro fertilization treatment outcome. Fertil Steril 67:889–899

    Article  CAS  PubMed  Google Scholar 

  10. Crosignani PG, Donini P (1994) The triggering of ovulation with partially desialylated HCG in HMG-stimulated cycles. In: Emperaire JC (ed) The triggering of ovulation in stimulated cycles: hCG or LH? The Parthenon Publishing Group, New York, pp 99–102

    Google Scholar 

  11. Le Cotonnec JY, Porchet HC, Beltrami V, Munafo A (1998) Clinical pharmacology of human luteinizing hormone. Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertil Steril 69:189–194

    Article  PubMed  Google Scholar 

  12. Damewood MD, Shen W, Zacur HA et al (1989) Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril 52:398–402

    CAS  PubMed  Google Scholar 

  13. Rizkallah T, Gurpide E, Van De Wiele RL (1969) Metabolism of HCG in man. J Clin Endocrinol Metab 29:92–100

    Article  CAS  PubMed  Google Scholar 

  14. Morse JH, Lustbader JW, Harrington JW, Canfield RE (1988) Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by western blotting. Am J Reprod Immunol 17:134–140

    CAS  Google Scholar 

  15. Bomsel-Helmreich O, Vun Nuyen L, Durand-Gasselin I (1989) Effects of varying doses of HCG on the evolution of preovulatory rabbit follicles and oocytes. Hum Reprod 4:636–642

    CAS  PubMed  Google Scholar 

  16. Brown JB (1978) Pituitary control of ovarian function – concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol 18:47–54

    Article  CAS  Google Scholar 

  17. Abdallah H, Ah-Moye M (1987) The effect of the dose of HCG and the type of gonadotropin stimulation on oocyte recovery rate. Fertil Steril 48:958–963

    Google Scholar 

  18. Salha O, Dada T, Sharma V (2001) Influence of body mass index and self-administration of HCG on the outcome of IVF cycles: a prospective cohort study. Hum Fertil 4:37–42

    Article  CAS  Google Scholar 

  19. Zelinski-Wooten MB, Hutchison JS, Trinchard-Lugan I et al (1997) Initiation of periovulatory events in gonadotropin-stimulated macaques with various doses of recombinant human chorionic gonadotropin. Hum Reprod 12:1877–1885

    Article  CAS  PubMed  Google Scholar 

  20. Emperaire JC, Parneix I, Broussin B, Ruffie A (1998) Triggering ovulation with different doses of human chorionic gonadotropin (hCG) in stimulated cycles. In: 16th World Congress on Fertility and Sterility, San Francisco, Abstr O-147, p 55

    Google Scholar 

  21. Fischer RA, Nakajima ST, Gibson M, Brumsted JR (1993) Ovulation after intravenous and intramuscular human chorionic gonadotropin. Fertil Steril 60:413–417

    Google Scholar 

  22. Chan CC, Ng EH, Tang OS et al (2005) A prospective, randomized double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase. J Clin Endocrinol Metab 90:3933–3938

    Article  CAS  PubMed  Google Scholar 

  23. Fuh KW, Wang X, Tai A et al (1997) Intra-uterine insemination: effect of temporal relationship between the luteinizing hormone surge, human chorionic gonadotropin administration, and insemination on pregnancy rates. Hum Reprod 12:2162–2166

    Article  CAS  PubMed  Google Scholar 

  24. Blockeel C, Knez J, Polyzos NP et al (2014) Should an intra-uterine insemination with donor semen be performed 1 or 2 days after the spontaneous LH rise? A prospective RCT. Hum Reprod 29:697–703

    Article  CAS  PubMed  Google Scholar 

  25. Emperaire JC (1994) Le declenchement therapeutique de l’ovulation: vers le remplacement de l’HCG par la LH. Contracept Fertil Sexual 22:459–467

    CAS  Google Scholar 

  26. Parneix I, Emperaire JC, Ruffie A (2001) Comparaison de differents protocoles de declenchement ovulatoire par les agonistes de la GnRH et la gonadotrophine chorionique. Gynecol Obstet Fertil 29:100–115

    Article  CAS  PubMed  Google Scholar 

  27. Iliodromiti S, Lan VT, Tuong HM et al (2013) Impact of GnRH agonist triggering and extensive luteal support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study. J Ovarian Res 6:93

    Article  PubMed Central  PubMed  Google Scholar 

  28. Emperaire JC, Parneix I, Ruffie A (2004) Luteal phase defects following agonist-triggered ovulation: a patient-dependent response. Reprod Biomed Online 9:22–27

    Article  CAS  PubMed  Google Scholar 

  29. The European Recombinant LH Study Group (2001) The recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 86:2607–2618

    Article  Google Scholar 

  30. Chandrasekher YA, Hutchison JS, Zelinski-Wooten MB et al (1994) Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the mid-cycle gonadotropin surge. J Clin Endocrinol Metab 79:298–306

    CAS  PubMed  Google Scholar 

  31. Jewelewicz R, James SL, Finster M et al (1972) Quintuplet gestation after ovulation induction with menopausal gonadotropins and pituitary luteinizing hormone. Obstet Gynecol 40:1–5

    CAS  PubMed  Google Scholar 

  32. Mehrotra S, Singh U, Gupta HP et al (2014) A prospective double blind study comparing the effects of oxytocin and human chorionic gonadotrophin as trigger for ovulation. J Obstet Gynecol 34:13–16

    Article  CAS  Google Scholar 

  33. Emperaire JC, Edwards RG (2004) Time to revolutionize the triggering of ovulation. Reprod Biomed Online 9:480–483

    Article  CAS  PubMed  Google Scholar 

  34. Emperaire JC (2005) Pourquoi continuer à tolérer l’hyperstimulation ovarienne? Gynecol Obstet Fertil 33:281–282

    Article  PubMed  Google Scholar 

  35. Caraty A, Evans NP, Fabre-Nys CJ, Karsch EJ (1995) The periovulatory gonadotropin-releasing hormone surge: a neuroendocrine signal for ovulation. J Reprod Fertil Suppl 49:245–255

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bordeaux, France

    Jean-Claude Emperaire

Authors
  1. Jean-Claude Emperaire
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Emperaire, JC. (2015). Triggering Ovulation. In: Ovulation Stimulation with Gonadotropins. Springer, Cham. https://doi.org/10.1007/978-3-319-18654-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18654-2_6

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18653-5

  • Online ISBN: 978-3-319-18654-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation